HealthAgents

HealthAgents is creating an agent-based distributed decision support system (DSS) for the diagnosis and prognosis of brain tumours. The HealthAgents system implements novel pattern recognition discrimination methods in order to analyse in vivo MRS and ex vivo/in vitro HR-MAS and DNA data. HealthAgents is not only applying advanced agent technology to the biomedical field, but also nurturing the HealthAgents network, a globally distributed information repository for brain tumour diagnosis and prognosis.

Brain tumours remain an important cause of morbidity and mortality and afflict an increasing percentage of aging adults with a crude incidence rate of 8 per 100,000 inhabitants in Europe. Diagnosis using Magnetic Resonance Imaging (MRI) is non-invasive, but only achieves 60-90 % accuracy, depending on the tumour type and grade. The current gold standard classification of a brain tumour by histopathological analysis of biopsy is an invasive surgical procedure and incurs a risk of 2.4-3.5% morbidity and 0.2-0.8% mortality, in addition to healthcare costs and stress to patients.There is a need to improve brain tumour classification, and to provide non-invasive methods for brain tumour diagnosis and prognosis, to aid patient management and treatment.

The HealthAgents project will deliver an opensource web-based DSS which provides hospitals and organisations with a reliable tool to aid in the diagnosis of brain tumours and their prognosis and avoid invasive surgical procedures.

The main objectives of the project are:

  • Improve the classification of brain tumours through multi-agent decision support over a distributed network of local databases.
  • Develop new pattern recognition methods for a distributed classification and analysis of high-resolution magic angle spinning (HR-MAS) and DNA data.
  • Define a method to assess the quality and usability of a new candidate local database containing a set of new cases, based on a quality score.
  • Compile, evaluate and use parameters to audit clas¬sifiers and improve them periodically.
  • Create the HealthAgents network, a globally distributed brain tumour information and knowledge repository comprising some of the leading European centres of excellence in neuro-oncology.

For further information, please visit:
http://www.healthagents.net

Project co-ordinator:
MicroArt (ES)

Partners:

  • MicroArt, SL (ES)
  • Universitat de València (ES)
  • Universitat Autònoma de Barcelona (ES)
  • Instituto de Aplicaciones de las TIC avanzadas (ES)
  • Pharma Quality Europe (IT)
  • Katholieke Universiteit Leuven (BE)
  • University of Birmingham (UK)
  • University of Edinburgh (UK)
  • University of Southampton (UK)

Timetable: from 01/06 – to 12/08

Total cost: € 4.106.879

EC funding: € 3.791.270

Instrument: STREP

Project Identifier: IST-2004-27214

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...